| CEO Name | William H. Lewis |
| Nationality | United States |
| Net Worth Estimation | $120 million |
William H. Lewis's estimated net worth of around $120 million is primarily derived from his significant equity holdings, option awards, and compensation as CEO of Insmed Incorporated. This valuation reflects accumulated stock awards, annual salary, bonuses, and appreciation in Insmed's share price under his tenure.
William H. Lewis, CEO of Insmed, has an estimated net worth of $120 million, exceeding the typical biotechnology CEO range of $10 million to $80 million by 50%. His net worth is 50% higher than the maximum estimated for CEOs in this business category.
Business Category: Biotechnology
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 80000000 USD
William H. Lewis Performance in Insmed
William H. Lewis, CEO of Insmed, demonstrates strategic leadership focused on innovative biopharmaceutical solutions for rare diseases. His decisive actions in advancing product pipelines and optimizing operational efficiency have significantly enhanced company performance and market positioning. Under his leadership, Insmed has achieved notable growth, strengthening its pipeline and shareholder value.
Latest News
Insmed Inc. and CEO Will Lewis: FDA Approvals and Growth Prospects
Insmed, led by CEO Will Lewis since 2012, is experiencing significant growth with FDA approval of its lung disease drug Brensocatib and European regulatory progress, driving stock gains and optimism for future drug launches and increased revenues. Lewis highlights the company's focus on serious rare diseases and the company's status as a top biopharma employer, underpinning strong clinical and commercial momentum in 2025.
Source: http://stockstotrade.com/news/insmed-incorporated-insm-news-2025_10_30/